Title: Why are most phospholipidosis inducers also hERG blockers?
Journal: Archives of toxicology 20171201
Title: Changes in optic nerve head circulation in response to vasoactive agents: intereye comparison in monkeys with experimental unilateral glaucoma.
Journal: Investigative ophthalmology & visual science 20120822
Title: Neuroprotection by lomerizine, a prophylactic drug for migraine, against hydrogen peroxide-induced hippocampal neurotoxicity.
Journal: Molecular and cellular biochemistry 20111201
Title: Development of spontaneous neuropathy in NF-κBp50-deficient mice by calcineurin-signal involving impaired NF-κB activation.
Journal: Molecular vision 20110101
Title: Interaction of CJZ3, a lomerizine derivative, with ATPase activity of human P-glycoprotein in doxorubicin-resistant human myelogenous leukemia (K562/DOX) cells.
Journal: Die Pharmazie 20100701
Title: Lomerizine, a Ca2+ channel blocker, protects against neuronal degeneration within the visual center of the brain after retinal damage in mice.
Journal: CNS neuroscience & therapeutics 20100401
Title: Limited restoration of visual function after partial optic nerve injury; a time course study using the calcium channel blocker lomerizine.
Journal: Brain research bulletin 20100316
Title: A case of ocular hypertension complicated by SUNCT syndrome.
Journal: Annals of ophthalmology (Skokie, Ill.) 20100101
Title: Secondary retinal ganglion cell death and the neuroprotective effects of the calcium channel blocker lomerizine.
Journal: Investigative ophthalmology & visual science 20091101
Title: Inhibitory effect of lomerizine, a prophylactic drug for migraines, on serotonin-induced contraction of the basilar artery.
Journal: Journal of pharmacological sciences 20091001
Title: [Calcium antagonists in the prophylactic treatment of migraine].
Journal: Brain and nerve = Shinkei kenkyu no shinpo 20091001
Title: Secondary degeneration of the optic nerve following partial transection: the benefits of lomerizine.
Journal: Experimental neurology 20090301
Title: Cognitive impairment and cerebral hypoperfusion in a CADASIL patient improved during administration of lomerizine.
Journal: Clinical neuropharmacology 20090101
Title: [CADASIL].
Journal: Brain and nerve = Shinkei kenkyu no shinpo 20081101
Title: Goshuyuto, a traditional Japanese medicine for migraine, inhibits platelet aggregation in guinea-pig whole blood.
Journal: Journal of pharmacological sciences 20080901
Title: Atypical depression as a premonitory symptom of migraine managed by an oral contraceptive.
Journal: Psychiatry and clinical neurosciences 20080601
Title: Migraine-associated vertigo: clinical characteristics of Japanese patients and effect of lomerizine, a calcium channel antagonist.
Journal: Acta oto-laryngologica. Supplementum 20071201
Title: CJZ3, a lomerizine derivative, modulates P-glycoprotein function in rat brain microvessel endothelial cells.
Journal: Acta pharmacologica Sinica 20060401
Title: A new calcium channel antagonist, lomerizine, alleviates secondary retinal ganglion cell death after optic nerve injury in the rat.
Journal: Current eye research 20060301
Title: [Reversal of multidrug resistance by lomerizine in K562/ADM cells].
Journal: Yao xue xue bao = Acta pharmaceutica Sinica 20040501
Title: Clinical potential of lomerizine, a Ca2+ channel blocker as an anti-glaucoma drug: effects on ocular circulation and retinal neuronal damage.
Journal: Cardiovascular drug reviews 20040101
Title: [Effects of changes in conformation and configuration of N-containing compounds on NMR spactra].
Journal: Yao xue xue bao = Acta pharmaceutica Sinica 20031201
Title: Effects of lomerizine, a calcium channel antagonist, on retinal and optic nerve head circulation in rabbits and humans.
Journal: Investigative ophthalmology & visual science 20031101
Title: Increase in doxorubicin cytotoxicity by inhibition of P-glycoprotein activity with lomerizine.
Journal: Biological & pharmaceutical bulletin 20010501
Title: Effects of lomerizine, a novel Ca2+ channel blocker, on the normal and endothelin-1-disturbed circulation in the optic nerve head of rabbits.
Journal: Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics 20010401
Title: Tran LT, et al. The voltage-gated calcium channel blocker Lomerizine is neuroprotective in motor neurons expressing mutant SOD1, but not TDP-43. J Neurochem. 2014 Aug;130(3):455-66.
Title: Zhu HJ, et al. [Reversal of multidrug resistance by Lomerizine in K562/ADM cells Yao Xue Xue Bao. 2004 May;39(5):333-7.
Title: Nakamura-Yanagidaira T, et al. Development of spontaneous neuropathy in NF-κBp50-deficient mice by calcineurin-signal involving impaired NF-κB activation. Mol Vis. 2011;17:2157-70.
Title: Shimazawa M, et al. Effects of Ca2+ channel blockers on cortical hypoperfusion and expression of c-Fos-like immunoreactivity after cortical spreading depression in rats. Br J Pharmacol. 1995 Aug;115(8):1359-68.
